Figure 3From: Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study Physician's evaluation of therapeutic response. Response expressed as mean relative to baseline. P = not significant. MF-DPI = mometasone furoate administered via a dry powder inhaler.Back to article page